Percutaneous absorption of antisense phosphorothioate oligonucleotide in vitro

Archives of Pharmacal Research

Volumn 19, Issue 2, 1996, Pages 116-121

  Lee, Young Mi ^a   Song, Kyung ^a   Lee, Sung Hee ^a   Ko, Geon Il ^a   Kim, Jae Baek ^a   Sohn, Dong Hwan ^a  

^a Wonkwang University   (South Korea)

Author keywords

Antisense oligonucleotide; Percutaneous absorption; Phosphorothioate; Transforming growth factor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; NONHUMAN; RAT; SKIN ABSORPTION; SKIN INJURY; SKIN PENETRATION;

EID: 0030428859     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976845     Document Type: Article

References (16)

1. Agrawal, S., Temsamani, J. and Tang, J. Y., Pharmacokinetics, biodistribution, and stability of oligonucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci., USA, 88, 7595-7599 (1991).
2. Akhtar, S., Kole, R. and Juliano, R.L., Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci., 49, 1793-1801 (1991).
3. Choi, B. M., Kim, S. U., Lee, S. Y. and Chung, H. T., Control of Scarring in adult wounds using antisense transforming growth factor β1. Antisense Res. Dev., 5, 96 (1995).
4. Chow, D. S. L, Kaka, I. and Wang, T. I., Concentration-dependent enhancement of 1-dodecylazacycloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide. J. Pharm. Sci., 73, 1794-1799 (1984).
5. Cromack, D. T., Sporn, M. B., Roberts, A. B., Merino, M. J., Dart, L. L. and Norton, J. A., Transforming growth factor ß levels in rat wound chambers. J. Sur. Res., 42, 622-628 (1987).
6. Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B. and Goeddel, D. V., Human transforming growth factor-ß complementary DNA sequence and expression in normal and transformed cells. Nature, 316, 701-705 (1985).
7. Hoke, G. D., Draper, K., Freier, S. M., Gonzalez, C., Driver, V. B., Zounes, M. C. and Ecker, D., Effect of phosphorothioate capping on antisense oligonucleotides stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res., 19, 5743-5748 (1991).
8. Jaroszewski, J.W. and Cohen, J. S., Cellular uptake of antisense oligodeoxynucleotides. Adv. Drug Delivery. Rev., 6, 235-250 (1991).
9. Nolen III, H. W., Catz, P., and Friend, D. R., Percutaneous penetration of methyl phosphonate antisense oligonucleotides. Int. J. Pharm., 107, 169-177 (1994).
10. Saffran, M., Kumar, G. S., Savariar, C., Burnham, J. C., Williams, F. and Neckers, D. C., A new approach to the oral administration of insulin and other peptide drugs. Reports, 233, 1081-1084 (1986).
11. Sharples, K., Plowman, G. D., Rose, T. M., Twardzik, D. R. and Purchio, A. F., Cloning and sequence analysis of simian transforming growth factor ß cDNA. DNA, 6, 239-244 (1987).
12. Shaw, J. P., Kent, K., Bird, J. and Froehler, B., Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acid Res., 19, 747-750 (1991).
13. Shoji, Y., Akhtar, S., Periasamy, A., Herman, B. and Juliano, R. L, Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. Nucleic Acids Res., 19, 5543-5550 (1991).
14. Sporn, M. B. and Roberts, A. B., Transforming Growth Factor ß; Multiple actions and potential clinical applications. JAMA, 262, 938-941 (1989).
15. Uhlman, E. and Peyman, A., Antisense oligonucleotides : A new therapeutic principle. Chem. Rev., 90, 544-584 (1990).
16. Whitby, D. J. and Ferguson, M. W. J., Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol., 147, 207-215 (1991).